A new trading day began on Tuesday, with Dyne Therapeutics Inc (NASDAQ: DYN) stock price down -4.01% from the previous day of trading, before settling in for the closing price of $21.67. DYN’s price has ranged from $6.36 to $31.32 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -59.45%. Meanwhile, its annual earnings per share averaged -5.21%. With a float of $104.93 million, this company’s outstanding shares have now reached $142.61 million.
Dyne Therapeutics Inc (DYN) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Dyne Therapeutics Inc is 26.53%, while institutional ownership is 83.58%. The most recent insider transaction that took place on Sep 05 ’25, was worth 35,402. In this transaction CEO & President of this company sold 2,640 shares at a rate of $13.41, taking the stock ownership to the 199,539 shares. Before that another transaction happened on Sep 04 ’25, when Company’s Chief Commercial Officer sold 894 for $13.27, making the entire transaction worth $11,863. This insider now owns 95,017 shares in total.
Dyne Therapeutics Inc (DYN) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.88 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.85 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -5.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.71% during the next five years compared to -59.45% drop over the previous five years of trading.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
Here are Dyne Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 13.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.66, a number that is poised to hit -0.78 in the next quarter and is forecasted to reach -3.37 in one year’s time.
Technical Analysis of Dyne Therapeutics Inc (DYN)
Looking closely at Dyne Therapeutics Inc (NASDAQ: DYN), its last 5-days average volume was 2.14 million, which is a drop from its year-to-date volume of 2.63 million. As of the previous 9 days, the stock’s Stochastic %D was 75.89%.
During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 74.93%, which indicates a significant increase from 71.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.70 in the past 14 days, which was higher than the 0.92 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.25, while its 200-day Moving Average is $12.87. However, in the short run, Dyne Therapeutics Inc’s stock first resistance to watch stands at $21.58. Second resistance stands at $22.36. The third major resistance level sits at $22.93. If the price goes on to break the first support level at $20.23, it is likely to go to the next support level at $19.66. Should the price break the second support level, the third support level stands at $18.88.
Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats
With a market capitalization of 2.97 billion, the company has a total of 142,825K Shares Outstanding. Currently, annual sales are 0 K while annual income is -317,420 K. The company’s previous quarter sales were 0 K while its latest quarter income was -108,040 K.
